News from NORD

NIH Workshop Focuses on Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Publish date: May 10, 2017

 

NIH recently hosted a workshop to bring researchers together to discuss severe drug reactions such as Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and possible genetic factors that might predispose individuals to greater risk.

Recommended Reading

Applications Are Being Accepted for Free Family Rare Disease Summer Camp
MDedge Cardiology
Largest-Ever Study of Pemphigus and Pemphigoid Launched
MDedge Cardiology
Pamela Gavin of NORD to Speak at Technology and Rare Neurological Diseases Symposium
MDedge Cardiology
Foundation for Prader-Willi Research Promotes Awareness of Guidelines Related to Use of Human Growth Hormone
MDedge Cardiology
Can public reporting improve pediatric heart surgery?
MDedge Cardiology
DTC genetic health risk tests: Beware
MDedge Cardiology
Cushing’s appears to begin its cardiovascular effects during childhood
MDedge Cardiology
Patient Advocacy Groups Oppose AHCA
MDedge Cardiology
NORD Issues RFPs for 2017 Research Grants for Study of Rare Diseases
MDedge Cardiology
NORD Rare Action Network Issues Spring 2017 State Policy Legislative Tracker
MDedge Cardiology